{
  "uuid" : "",
  "id" : "bwh_t_stage_cSCC.v0.0.1",
  "gdl_version" : "2.1",
  "concept" : "gt0001",
  "language" : {
    "original_language" : "ISO_639-1::en"
  },
  "description" : {
    "original_author" : {
      "name" : "Katja Mariko Wilde",
      "email" : "katja-wilde@t-online.de",
      "organisation" : "Cambio CDS",
      "date" : "2026-01-16"
    },
    "lifecycle_state" : "DRAFTED",
    "details" : {
      "en" : {
        "id" : "en",
        "purpose" : "To calculate the total number of BWH high-risk factors and assign the corresponding BWH T stage in order to stratify primary cutaneous squamous cell carcinoma into postoperative low-risk or high-risk categories.",
        "keywords" : [
          "bwh",
          "brigham",
          "womens",
          "hospital",
          "cutaneous",
          "squamous",
          "cell",
          "carcinoma"
        ],
        "use" : "Use to stage and risk stratify adult patients with primary cutaneous squamous cell carcinoma without nodal or distant metastases according to the Brigham and Women’s Hospital (BWH) classification.\n\nThe guideline evaluates the presence of BWH-defined high-risk factors:\n- Clinical tumour diameter ≥ 2 cm\n- Tumour invasion beyond subcutaneous fat\n- Poor histological differentiation\n- Perineural invasion involving nerves with diameter ≥ 0.1 mm\n\nBone invasion is assessed separately and, if present, directly assigns the highest T stage.\n\nThe total number of high-risk factors is calculated and used to assign the BWH T stage:\n- BWH-T1: 0 risk factors\n- BWH-T2a: 1 risk factor\n- BWH-T2b: 2–3 risk factors\n- BWH-T3: 4 risk factors or bone invasion\n\nBased on the assigned BWH T stage, the guideline classifies the tumour as postoperative low-risk (BWH-T1, BWH-T2a) or high-risk (BWH-T2b, BWH-T3), supporting prognosis estimation and follow-up planning.",
        "misuse" : "Not to be used for TNM staging, for assessment of nodal or distant metastatic disease, or for cancer registry reporting.",
        "copyright" : "© Cambio CDS"
      }
    },
    "other_details" : {
      "references" : "Regionala cancercentrum i samverkan. Nationellt vårdprogram skivepitelcancer i huden: Kapitel 8 Kategorisering av tumören. Kunskapsbanken, 2021. Available at: https://kunskapsbanken.cancercentrum.se/diagnoser/skivepitelcancer-i-huden/vardprogram/kategorisering-av-tumoren/\n\nKaria PS, Jambusaria-Pahlajani A, Harrington DP, Murphy GF, Qureshi AA, Schmults CD. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol. 2014 Feb 1;32(4):327-34. doi: 10.1200/JCO.2012.48.5326. Epub 2013 Dec 23. PMID: 24366933; PMCID: PMC3897257.",
      "en" : "A structured staging and risk stratification guideline used to classify primary cutaneous squamous cell carcinoma (cSCC) without metastatic disease according to the Brigham and Women’s Hospital (BWH) T-staging system."
    }
  },
  "definition" : { },
  "ontology" : {
    "term_definitions" : {
      "en" : {
        "id" : "en",
        "terms" : {
          "gt0001" : {
            "id" : "gt0001",
            "text" : "Brigham and Women’s Hospital (BWH) T staging for cutaneous squamous cell carcinoma (cSCC)",
            "description" : "A structured staging and risk stratification guideline used to classify primary cutaneous squamous cell carcinoma (cSCC) without metastatic disease according to the Brigham and Women’s Hospital (BWH) T-staging system."
          }
        }
      }
    }
  }
}